ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis

This study has been completed.
Study NCT00004816.   Last updated on June 23, 2005.   Information provided by Office of Rare Diseases (ORD)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Multiple Sclerosis
2 Additional conditions recognized in this trial
Sclerosis
3 More general conditions related to this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Demyelinating Autoimmune Diseases, CNS
Demyelinating Diseases
Immune System Diseases
Nervous System Diseases
Pathologic Processes
4 Interventions listed in this trial
monoclonal antibody M-T412
5 Additional drug interventions recognized in this trial
Antibodies
Antibodies, Monoclonal
6 More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
7 Sponsors listed in this trial
National Center for Research Resources (NCRR)
Stanford University




Links to all studies - primarily for crawlers